To establish a Federal strategy for preventing, diagnosing, and treating nonalcoholic steatohepatitis, commonly referred to as "NASH".
Nonalcoholic Steatohepatitis Care Act of 2020 or the NASH Care Act of 2020
This bill reauthorizes, establishes, or expands various grants, research, disease surveillance, and other efforts to prevent, diagnose, and treat nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (i.e., liver inflammation and damage caused by a buildup of fat in the liver).
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line